Keywords

benralizumab, ertugliflozin L-pyroglutamic acid, netarsudil dimesylate, ozenoxacin, semaglutide, tezacaftor/ivacaftor, voretigene neparvovec-rzyl

Authors

1. Hussar, Daniel A. PhD

Abstract

Abstract: This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.